Correction: Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts

Lingjian Yang; Laura Forker; Joely J. Irlam; Nischalan Pillay; Ananya Choudhury; Catharine M.L. West

doi:10.18632/oncotarget.26783

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts

PDF | How to cite

Oncotarget. 2019; 10:2007-2007. https://doi.org/10.18632/oncotarget.26783

Metrics: PDF 2237 views | ?

Lingjian Yang¹, Laura Forker¹, Joely J. Irlam¹, Nischalan Pillay^2,3, Ananya Choudhury¹ and Catharine M.L. West^1,4

¹ Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, UK
² Cancer Institute, University College London, London, UK
³ Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK
⁴ NIHR Manchester Biomedical Research Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK

Published: March 08, 2019

This article has been corrected: The correct Acknowledgments information is given below:

ACKNOWLEDGMENTS

We thank Leo Zeef and Andy Hayes of the Bioinformatics and Genomic Technologies Core Facilities at the University of Manchester for providing support with regard to RNAseq. This work was funded by a Cancer Research UK Major Centre award [C147/A18083]; Sarcoma UK (SUK205.2016); and the NIHR Manchester Biomedical Research Centre. The results here are partly based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.

Original article: Oncotarget. 2018; 9:3946-3955. DOI: https://doi.org/10.18632/oncotarget.23280.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26783

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts